Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 12749424)

1.

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.

Stelling JR, Chapman ET, Frankfurter D, Harris DH, Oskowitz SP, Reindollar RH.

Fertil Steril. 2003 Apr;79(4):881-5.

PMID:
12749424
2.
4.

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.

Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG.

Fertil Steril. 2008 Dec;90(6):2133-7. doi: 10.1016/j.fertnstert.2007.10.015. Epub 2008 Jan 4.

PMID:
18177866
5.

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.

Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M.

Fertil Steril. 2006 Oct;86(4):830-8. Epub 2006 Sep 11.

PMID:
16963040
6.
7.

Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme.

Wikland M, Borg J, Forsberg AS, Jakobsson AH, Svalander P, Waldenström U.

Hum Reprod. 1995 Jul;10(7):1667-70.

PMID:
8582958
8.

In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.

Raziel A, Schachter M, Strassburger D, Kasterstein E, Ron-El R, Friedler S.

Fertil Steril. 2006 Sep;86(3):583-7. Epub 2006 Jul 7.

PMID:
16828475
11.

Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.

Laufer N, DeCherney AH, Tarlatzis BC, Zuckerman AL, Polan ML, Dlugi AM, Graebe R, Barnea ER, Naftolin F.

Fertil Steril. 1984 Aug;42(2):198-203.

PMID:
6430722
12.
13.

The empty follicle syndrome: a pharmaceutical industry syndrome.

Zegers-Hochschild F, Fernández E, Mackenna A, Fabres C, Altieri E, Lopez T.

Hum Reprod. 1995 Sep;10(9):2262-5.

PMID:
8530648
14.

Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles.

Koo YA, Lee B, Park HJ, Choi J, Lee E, Choi D.

Fertil Steril. 2009 Mar;91(3):744-8. doi: 10.1016/j.fertnstert.2007.12.068. Epub 2008 Mar 5.

PMID:
18321491
15.

[Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].

Tsagareishvili GG.

Georgian Med News. 2005 Feb;(119):18-23. Russian.

PMID:
15834173
16.

Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.

Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B.

Fertil Steril. 2005 Aug;84(2):394-401.

PMID:
16084880
18.

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.

Schmidt DW, Maier DB, Nulsen JC, Benadiva CA.

Fertil Steril. 2004 Oct;82(4):841-6.

PMID:
15482757
19.

Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization.

Nagata Y, Honjou K, Sonoda M, Sumii Y, Inoue Y, Kawarabayashi T.

Fertil Steril. 1999 Aug;72(2):235-9.

PMID:
10438987
20.

Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?

Reichman DE, Greenwood E, Meyer L, Kligman I, Rosenwaks Z.

Fertil Steril. 2012 Sep;98(3):671-4. doi: 10.1016/j.fertnstert.2012.05.050. Epub 2012 Jul 4.

PMID:
22769734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk